文献速递前列腺癌

根治性放疗后前列腺癌局部失败事件:前列腺癌随机试验荟萃分析联盟(LEVIATHAN)18项随机试验的汇总分析

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).
PubMed 文献 · Eur Urol · 2022-08-05

该汇总分析纳入18项随机试验中12533例中高危前列腺癌患者,随访中位11年。高危患者局部失败795例(13%)、远处转移1288例(21%);中危患者分别为449例(7.2%)和451例(7.2%)。局部失败是高危患者总生存、前列腺癌特异性生存和无远处转移生存的独立预后因素,也是中危患者无远处转移生存的预后因素;远处转移主要从临床无复发生存状态发生。

要点

  • 中位随访11年,高危患者局部失败795例(13%)、远处转移1288例(21%)。
  • 局部失败与高危患者OS(HR 1.17)、PCSS(HR 2.02)、DMFS(HR 1.94)显著相关。
  • 两组合计81%的远处转移发生于临床无复发生存状态。

核心结论

  • 局部失败是高危前列腺癌患者总生存、前列腺癌特异性生存和无远处转移生存的独立预后因素,也是中危患者无远处转移生存的预后因素。
  • 远处转移主要从临床无复发生存状态发生,强调处理隐匿性微病灶的重要性;局部失败事件后出现「第二波」远处转移,优化局部控制可能降低远处转移风险。

研究设计与样本

  • 基于前列腺癌随机试验荟萃分析联盟(MARTCP)18项随机试验(1985年至2015年间开展)中12533例前列腺癌患者(高危6288例、中危6245例)个体患者数据的汇总分析。
  • 采用多变量Cox比例风险模型评估总生存、前列腺癌特异性生存、无远处转移生存与作为时间依赖协变量的局部失败之间的关系。
  • 采用马尔可夫比例风险模型评估特定转移状态的影响。

主要发现

  • 中位随访11年;高危患者局部失败795例(13%)、远处转移1288例(21%);中危患者局部失败449例(7.2%)、远处转移451例(7.2%)。
  • 两组中81%的远处转移从临床无复发生存状态发生。
  • 高危患者中,局部失败与OS(HR 1.17,95%CI 1.06-1.30)、PCSS(HR 2.02,95%CI 1.75-2.33)、DMFS(HR 1.94,95%CI 1.75-2.15,所有P<0.01)显著相关。
  • 中危患者中,局部失败与DMFS(HR 1.57,95%CI 1.36-1.81)显著相关,但与OS无显著相关。
  • 无局部失败患者向前列腺癌特异性死亡状态转移的风险显著低于有局部失败者(HR 0.32,95%CI 0.21-0.50,P<0.001);在较晚时间点,两组均有更多远处转移在局部失败事件后出现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The prognostic importance of local failure after definitive radiotherapy (RT) in National Comprehensive Cancer Network intermediate- and high-risk prostate cancer (PCa) patients remains unclear. OBJECTIVE: To evaluate the prognostic impact of local failure and the kinetics of distant metastasis following RT. EVIDENCE ACQUISITION: A pooled analysis was performed on individual patient data of 12 533 PCa (6288 high-risk and 6245 intermediate-risk) patients enrolled in 18 randomized trials (conducted between 1985 and 2015) within the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium. Multivariable Cox proportional hazard (PH) models were developed to evaluate the relationship between overall survival (OS), PCa-specific survival (PCSS), distant metastasis-free survival (DMFS), and local failure as a time-dependent covariate. Markov PH models were developed to evaluate the impact of specific transition states. EVIDENCE SYNTHESIS: The median follow-up was 11 yr. There were 795 (13%) local failure events and 1288 (21%) distant metastases for high-risk patients and 449 (7.2%) and 451 (7.2%) for intermediate-risk patients, respectively. For both groups, 81% of distant metastases developed from a clinically relapse-free state (cRF state). Local failure was significantly associated with OS (hazard ratio [HR] 1.17, 95% confidence interval [CI] 1.06-1.30), PCSS (HR 2.02, 95% CI 1.75-2.33), and DMFS (HR 1.94, 95% CI 1.75-2.15, p < 0.01 for all) in high-risk patients. Local failure was also significantly associated with DMFS (HR 1.57, 95% CI 1.36-1.81) but not with OS in intermediate-risk patients. Patients without local failure had a significantly lower HR of transitioning to a PCa-specific death state than those who had local failure (HR 0.32, 95% CI 0.21-0.50, p < 0.001). At later time points, more distant metastases emerged after a local failure event for both groups. CONCLUSIONS: Local failure is an independent prognosticator of OS, PCSS, and DMFS in high-risk and of DMFS in intermediate-risk PCa. Distant metastasis predominantly developed from the cRF state, underscoring the importance of addressing occult microscopic disease. However a "second wave" of distant metastases occurs subsequent to local failure events, and optimization of local control may reduce the risk of distant metastasis. PATIENT SUMMARY: Among men receiving definitive radiation therapy for high- and intermediate-risk prostate cancer, about 10% experience local recurrence, and they are at significantly increased risks of further disease progression. About 80% of patients who develop distant metastasis do not have a detectable local recurrence preceding it.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Ma TM, Chu FI, Sandler H, et al. Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN). Eur Urol. 2022. PMID: 35934601. doi:10.1016/j.eururo.2022.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。